Health & Medicine
A drug may help people on GLP-1 meds preserve muscle
In a clinical trial, an experimental antibody reduced lean-mass loss in people on a GLP-1 drug. Whether that improves health is unclear.
By Meghan Rosen
Every print subscription comes with full digital access
In a clinical trial, an experimental antibody reduced lean-mass loss in people on a GLP-1 drug. Whether that improves health is unclear.
We summarize the week's scientific breakthroughs every Thursday.
The cold-loving yeasts from Ötzi’s remains suggest the Iceman’s microbiome may not be completely frozen in time.
A new survey estimates 8 million young people use AI chatbots for help when stressed, angry or sad, an increase from 2024.
Tones, oddball sounds and words can spark brain cell responses, hinting at nuanced processing without consciousness.
Daraxonrasib, which nearly doubled patients' survival time, fights the disease in a new way. It bear-hugs a cancer protein that drives cell growth.
Lab experiments suggest mosquitoes can smell DEET and learn to associate it with food, but it’s unclear whether that happens in the wild.
The new test may catch active tuberculosis in those with low access to health care or who have trouble making the phlegm needed for traditional tests.
Andes hantavirus causes deadly lung failure, but its method of attack differs from other respiratory illnesses. The details might inform future treatments.
As Congo’s Bundibugyo Ebola outbreak grows, public health responders are turning to old-school tactics to fight it as scientists search for new tools.
A noninvasive treatment called high-intensity focused ultrasound helped relieve the shaking, stiffness and pain that accompany Parkinson’s disease.
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.
Not a subscriber?
Become one now.